Topics: Dementia

While drug companies have been working hard to come up with new options for the treatment of dementia, there have been no new FDA approvals since memantine (Namenda) hit the scene in 2003.

Let’s assume that you have already diagnosed a patient with Alzheimer’s Disease (AD). Your patient has received a full workup to rule out medical causes, has had a full battery of neuropsychological tests, and you have started a standard cocktail of whichever cholinesterase inhibitor you prefer.

As a neurologist, how do you approach the evaluation of dementia symptoms?

Topics: Antipsychotics | Natural Medications

Omega 3 fatty acids were once thought to be a possible treatment for mood disorders—but recent studies have been unimpressive.

Topics: Antidepressants | Bipolar Disorder

The frequency of antidepressant induced mania has been elusive, with some studies finding high rates of manic switching and others finding very few or no manic episodes among patients taking antidepressants.

Topics: OCD

Previous research has shown that a single dose of d-amphetamine 30 mg (as monotherapy) relieves symptoms of OCD better than a placebo ...